86 studies found for:    Open Studies | "Salivary Gland Diseases"
Show Display Options
Rank Status Study
21 Recruiting Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Conditions: Head and Neck Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharynx Carcinoma;   Recurrent Salivary Gland Carcinoma;   Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary;   Stage III Major Salivary Gland Carcinoma;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Carcinoma;   Stage IV Nasopharyngeal Carcinoma;   Stage IVA Major Salivary Gland Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Major Salivary Gland Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Major Salivary Gland Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vorinostat
22 Recruiting Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors
Conditions: Parotid Neoplasms;   Facial Paralysis
Intervention: Behavioral: Facial exercises
23 Recruiting A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Interventions: Drug: KCT-0809 ophthalmic solution;   Drug: Placebo
24 Recruiting An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Intervention: Drug: KCT-0809 ophthalmic solution
25 Recruiting A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Intervention: Drug: KCT-0809 ophthalmic solution
26 Recruiting Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Conditions: Head and Neck Carcinoma;   Xerostomia
Interventions: Other: Quality-of-Life Assessment;   Procedure: Transcutaneous Acupoint Electrical Stimulation
27 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
28 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
Intervention:
29 Not yet recruiting Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction
Conditions: Squamous Cell Head and Neck Cancer;   Radiation Induced Xerostomia;   Salivary Hypofunction
Intervention: Biological: AAV2hAQP1
30 Recruiting Sjögren's Biomarker Study
Conditions: Healthy;   Sjögren's Syndrome
Intervention:
31 Recruiting A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream
32 Not yet recruiting Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
Conditions: Salivary Gland Cancer;   Nasopharyngeal Carcinoma
Intervention:
33 Not yet recruiting Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease
Conditions: Sialorrhea;   Parkinson's Disease
Interventions: Drug: Glycopyrrolate;   Drug: Placebo
34 Not yet recruiting the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
35 Recruiting Effect of Childhood Radioiodine Therapy on Salivary Function
Conditions: Xerostomia;   Hyperthyroidism;   Thyroid Cancer
Intervention: Other: Radioiodine
36 Not yet recruiting Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Cyclosporin A;   Drug: Prednisone;   Drug: Placebo;   Drug: Calcium carbonate D
37 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
38 Recruiting Feasibility Study of MRI Imaging on Parotid Gland Stimulation
Condition: Parotid Neoplasms
Interventions: Device: MRI;   Other: Citric acid;   Other: Gadovist
39 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active - Cohort 1;   Drug: CFZ533 placebo- Cohort 1;   Drug: CFZ533 active - Cohort 2;   Drug: CFZ533 placebo - Cohort 2
40 Recruiting Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
Conditions: Chronic Troublesome Sialorrhea;   Cerebral Palsy;   Stroke;   Traumatic Brain Injury;   Intellectual Disability
Interventions: Drug: IncobotulinumtoxinA;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years